Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Miami-Fort Lauderdale-Pompano Beach, FL MSA — October 2026
Miami's labor tightness collides with a national life sci talent gap.
Miami-Dade unemployment at 1.9% and local compensation costs up 3.6% are compounding a national shortage in regulatory, clinical, and CMC talent, with Clinical Data Manager pay in Miami ($142,800) now running ahead of the national median ($123,653).
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Miami-Dade unemployment rate: 1.9% — Down from 2.9% a year ago; vs 4.1% national
- Miami-area compensation cost growth: 3.6% — Year ended June 2026, private industry
- Florida open life science jobs: 8,167 — Widest gaps in regulatory, medical affairs, quality
- National biopharma quit rate: 1.9% — Signals limited voluntary mobility despite hiring demand
Key takeaways
Clinical Research Associate pay gap signals a retention exposure.
Miami's CRA advertised median of $65,000 sits roughly 28% below the national figure of $90,065, even as national CRA demand remains candidate-driven and experienced professionals stay put. Local sponsors and CROs recruiting against national or hybrid-remote competitors may find this gap a structural disadvantage in closing both entry-level and experienced hires.
Regulatory Affairs pay holding steady while national rates soften.
Metro Regulatory Affairs Specialist pay is flat at $98,634 while the national median has moved down moderately to $103,780, narrowing the usual metro discount. Florida's documented regulatory talent gap suggests this stability reflects sustained local demand, a signal worth tracking against actual time-to-fill data.
Biostatistician compensation diverges sharply from the national trend.
Miami's biostatistician median advertised pay dropped to $86,317, a moderate decline, while the national figure held essentially flat near $131,958 — a gap exceeding $45,000. That spread may reflect a thinner local employer base more than reduced skill value, and could complicate recruiting for sponsors trying to build biostatistics capability locally alongside remote or CRO-based talent.
Clinical Data Manager pay in Miami outpaces the national rate.
Metro Clinical Data Manager compensation at $142,800 runs ahead of the $123,653 national median, an unusual inversion for a technical, largely remote-capable role. Current conditions suggest Miami employers are paying above-market rates to localize data management talent, worth testing against whether remote sourcing could relieve that premium.
Median advertised pay by role — Miami-Fort Lauderdale-Pompano Beach, FL MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $87,113 | $124,800 | $128,937 | Significant increase | $130,339 |
| Clinical Research Associate | $57,200 | $65,000 | $72,000 | Moderate increase | $90,065 |
| Lab Technician | $38,656 | $46,147 | $55,200 | Stable | $47,840 |
| Regulatory Affairs Specialist | $70,081 | $98,634 | $119,464 | Stable | $103,780 |
| Clinical Data Manager | $140,789 | $142,800 | $150,039 | Stable | $123,653 |
| Biostatistician | $68,049 | $86,317 | $94,356 | Moderate decline | $131,958 |
| Validation Engineer | $90,061 | $98,800 | $134,933 | Stable | $106,478 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Miami-Dade's unemployment rate fell to 1.9% in September — a full point below the year-ago figure and well under the national 4.1% — a reflection of broader metro labor tightness compounding scarcity in credential-dependent scientific and regulatory roles. Private-sector compensation costs in the Miami area rose 3.6% year-over-year through June, outpacing the 2.4% national advertised wage growth tracked by Indeed, signaling employers here are paying a premium to compete for talent in a market with little slack left to absorb life sciences hiring demand.
What it means
Metro-level labor tightness layers directly onto a national life sciences talent shortage in regulatory affairs, clinical operations, and CMC — functions where Florida employers already report the widest talent gaps and longest searches. With Miami-Dade unemployment near historic lows and a national quit rate of just 1.9%, counteroffer activity for Director and Senior Director-level regulatory and quality talent is likely to intensify, pushing some manufacturing and clinical scale-up decisions toward CDMO and CRO partners as internal build-out becomes harder to staff. Organizations should evaluate whether current regulatory and clinical operations compensation bands reflect Miami's tighter local labor conditions alongside national or Florida-wide figures.
Looking ahead
Worth watching: Miami-Dade's unemployment rate has fallen a full point year-over-year to 1.9%, among the tightest in Florida. Watch whether this tightening extends into scientific and regulatory job categories specifically, which would further compress an already thin regulatory affairs and CMC candidate pool.
Emerging pressure point: Statewide reports show 36% of Florida manufacturing facilities cannot hire process development staff and 27% lack sufficient process engineers. Expansion plans tied to Florida's position among the eight target states for pharma manufacturing may stall or shift toward CDMO partnerships if Miami-area staffing gaps mirror the state pattern.
Policy-driven demand: EUDAMED's May 2026 rollout and EU AI Act implementation are driving premium pay for AI compliance and UDI specialists nationally. Miami-based device and diagnostics employers with EU-market exposure should expect this demand to surface locally as global compliance functions recruit against a thin specialist pool.
Potential inflection point: National quit rates remain low at 1.9%, meaning most movement in regulatory, clinical operations, and CMC talent will come through active counteroffers more than open-market searches. Track whether Miami employers are increasing retention-focused pay actions to fill critical roles, alongside new-hire recruiting.
Sources
- Florida Department of Commerce / CareerSource South Florida — Miami-Dade unemployment rate fell to 1.9% in September 2026
- Bureau of Labor Statistics — Miami-area compensation costs rose 3.6% year-over-year through June 2026
- Bureau of Labor Statistics / industry survey — National quit rate sits at 1.9% despite active biopharma recruiting
- Industry workforce survey — 36% of Florida manufacturing facilities cannot hire process development staff
- Florida life sciences workforce report — Florida life sciences talent gaps widest in regulatory, medical affairs, quality
- Florida life sciences workforce report — Florida has 8,167 open life science jobs
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.